Literature DB >> 30345626

The short-term efficacy of combined treatments targeting B cell and plasma cell in severe and refractory Anti-N-methyl-D-aspartate receptor encephalitis: Two case reports.

Xiao-Ting Zhang1,2, Chun-Juan Wang1, Bao-Jie Wang1, Shou-Gang Guo1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30345626      PMCID: PMC6436585          DOI: 10.1111/cns.13078

Source DB:  PubMed          Journal:  CNS Neurosci Ther        ISSN: 1755-5930            Impact factor:   5.243


× No keyword cloud information.
  10 in total

Review 1.  Long-lived autoreactive plasma cells drive persistent autoimmune inflammation.

Authors:  Falk Hiepe; Thomas Dörner; Anja E Hauser; Bimba F Hoyer; Henrik Mei; Andreas Radbruch
Journal:  Nat Rev Rheumatol       Date:  2011-02-01       Impact factor: 20.543

2.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

3.  Bortezomib Treatment for Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Authors:  Volker Behrendt; Christos Krogias; Anke Reinacher-Schick; Ralf Gold; Ingo Kleiter
Journal:  JAMA Neurol       Date:  2016-10-01       Impact factor: 18.302

4.  Bortezomib for treatment of therapy-refractory anti-NMDA receptor encephalitis.

Authors:  Franziska Scheibe; Harald Prüss; Annerose M Mengel; Siegfried Kohler; Astrid Nümann; Martin Köhnlein; Klemens Ruprecht; Tobias Alexander; Falk Hiepe; Andreas Meisel
Journal:  Neurology       Date:  2016-12-21       Impact factor: 9.910

5.  Lower dosages of rituximab used successfully in the treatment of anti-NMDA receptor encephalitis without tumour.

Authors:  Bao-Jie Wang; Chun-Juan Wang; Zi-Ling Zeng; Yang Yang; Shou-Gang Guo
Journal:  J Neurol Sci       Date:  2017-04-08       Impact factor: 3.181

6.  Proteasome inhibition with bortezomib induces a therapeutically relevant depletion of plasma cells in SLE but does not target their precursors.

Authors:  Tobias Alexander; Qingyu Cheng; Jens Klotsche; Laleh Khodadadi; Aderajew Waka; Robert Biesen; Bimba F Hoyer; Gerd R Burmester; Andreas Radbruch; Falk Hiepe
Journal:  Eur J Immunol       Date:  2018-07-30       Impact factor: 5.532

7.  Extra-central nervous system target for assessment and treatment in refractory anti-N-methyl-d-aspartate receptor encephalitis.

Authors:  David W Nauen
Journal:  J Crit Care       Date:  2016-09-22       Impact factor: 3.425

8.  Acute mechanisms underlying antibody effects in anti-N-methyl-D-aspartate receptor encephalitis.

Authors:  Emilia H Moscato; Xiaoyu Peng; Ankit Jain; Thomas D Parsons; Josep Dalmau; Rita J Balice-Gordon
Journal:  Ann Neurol       Date:  2014-06-27       Impact factor: 10.422

Review 9.  Targeting B Cells and Plasma Cells in Autoimmune Diseases.

Authors:  Katharina Hofmann; Ann-Katrin Clauder; Rudolf Armin Manz
Journal:  Front Immunol       Date:  2018-04-23       Impact factor: 7.561

10.  NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody.

Authors:  Manish Malviya; Sumanta Barman; Kristin S Golombeck; Jesús Planagumà; Francesco Mannara; Nathalie Strutz-Seebohm; Claudia Wrzos; Fatih Demir; Christine Baksmeier; Julia Steckel; Kim Kristin Falk; Catharina C Gross; Stjepana Kovac; Kathrin Bönte; Andreas Johnen; Klaus-Peter Wandinger; Elena Martín-García; Albert J Becker; Christian E Elger; Nikolaj Klöcker; Heinz Wiendl; Sven G Meuth; Hans-Peter Hartung; Guiscard Seebohm; Frank Leypoldt; Rafael Maldonado; Christine Stadelmann; Josep Dalmau; Nico Melzer; Norbert Goebels
Journal:  Ann Clin Transl Neurol       Date:  2017-10-03       Impact factor: 4.511

  10 in total
  3 in total

Review 1.  Recent research on immunotherapy for anti-N-methyl-D-aspartate receptor encephalitis.

Authors:  Yu-Hang Li; Li Jiang
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-08-15

2.  Role of Increased Syncytin-1 Expression in Pathogenesis of Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Authors:  Shan Qiao; Quan-Ye Sun; Shan-Chao Zhang; Ran-Ran Zhang; Yu-Jiao Wu; Zhi-Hao Wang; Xue-Wu Liu
Journal:  Neuropsychiatr Dis Treat       Date:  2022-07-29       Impact factor: 2.989

Review 3.  Treatment Options in Refractory Autoimmune Encephalitis.

Authors:  Alessandro Dinoto; Sergio Ferrari; Sara Mariotto
Journal:  CNS Drugs       Date:  2022-08-02       Impact factor: 6.497

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.